Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
Frontiers in Pharmacology|November 29, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinomaYosuke Shibata, Takeshi Kishida, Taku Kouro, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|September 11, 2024
Retrospective Observational Study on Telemedicine in Sublingual Immunotherapy for Patients with Japanese Cedar Pollinosis and House Dust Mite Allergic RhinitisYumi Inoo, Hiroshi Iida, Hiroto Nakada, et al.World Journal of Surgical Oncology|February 20, 2021
Does the Endoscopic Surgical Skill Qualification System improve patients' outcome following laparoscopic surgery for colon cancer? A multicentre, retrospective analysis with propensity score matchingKeisuke Kazama, Masakatsu Numata, Toru Aoyama, et al.Heart and Vessels|June 14, 2020
Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary interventionMasayoshi Kiyokuni, Masaaki Konishi, Yusuke Saigusa, et al.BMC Psychiatry|February 20, 2020
The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapineSaki Hattori, Akira Suda, Masatoshi Miyauchi, et al.Cancer Chemotherapy and Pharmacology|December 8, 2018
Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205)Yusuke Suwa, Jun Watanabe, Mitsuyoshi Ota, et al.BMC Cancer|March 7, 2023
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamideTakashi Kawahara, Yusuke Saigusa, Shuko Yoneyama, et al.Annals of Gastroenterological Surgery|November 6, 2023
Exploratory randomized phase II trial for optimizing treatment dosage and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer: YCOG1402 (SOAP trial)Yusuke Suwa, Jun Watanabe, Hirokazu Suwa, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 12, 2020
Low-density-lipoprotein apheresis-mediated endothelial activation therapy to severe-peripheral artery disease study: Rationale and study designEiko Ueda, Yoshiyuki Toya, Hiromichi Wakui, et al.General Thoracic and Cardiovascular Surgery|June 24, 2026
Unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery: prolonged pleural effusion and pleural thickening as early postoperative indicatorsAkimasa Sekine, Kenji Inafuku, Masashi Nishimura, et al.Pageof 13